![Hal Chapman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hal Chapman is the founder of Pliant Therapeutics, Inc. (founded in 2015).
He is currently a Member at the Cardiovascular Research Institute and a Professor at UCSF School of Pharmacy.
Dr. Chapman obtained a doctorate degree from The University of Alabama.
| Unternehmen | Position | Beginn |
|---|---|---|
UCSF School of Pharmacy
 UCSF School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Cardiovascular Research Institute
 Cardiovascular Research Institute Miscellaneous Commercial ServicesCommercial Services Operates cardiovascular research institute | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
The University of Alabama
 The University of Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pliant Therapeutics, Inc.
 Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
Cardiovascular Research Institute
Cardiovascular Research Institute Miscellaneous Commercial ServicesCommercial Services Operates cardiovascular research institute | Commercial Services |
UCSF School of Pharmacy
UCSF School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
